Jean-Jacques Bertrand

Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France.

Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris.

Muzicall Ltd. provides ringback tone services. It offers its services for mobile operators, corporates, charities, advertising and media companies. The firm offers ringback tone services for fun, business and advertisements. The company was founded in 2004 by Mark Collins and Richard Nigel Curzon Jackson and is headquartered in London, the United Kingdom.

B3G SA provides broadband telephone operating services. The firm offers b-initial, b-direct, b-centrex, and b-specific services. It serves Internet service providers, cable companies, regional operators, and telecommunication and multimedia professionals. It has operations in France, Italy, Great Britain, Belgium, Denmark, Bulgaria, Romania, and Turkey. The company was founded in 2001 and is headquartered in La Défense, France.